Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2026 18:57 ET | Source: Block & Leviton LLP

BREAKING: ADMA Biologics Shares Fall Over 24%; Investors Encouraged to Contact Block & Leviton to Possibly Recover Losses

Block & Leviton is investigating ADMA Biologics, Inc. (Nasdaq: ADMA) for potential securities fraud. Investors should contact the firm to recover losses.
March 04, 2025 13:50 ET | Source: Block & Leviton LLP

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

Block & Leviton is investigating ADMA Biologics for potential securities fraud. Investors who lost money in ADMA should contact the firm to learn more.